Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for control of refractory asthma
IRCT20100102002954N21Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of azithromycin in asthma and severe asthma (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoints: Severity of chronic asthma and Forced expiratory volume in 1 second (FEV1). Started Oct 2020; status: completed.
02
Drugs
azithromycin
03
Conditions
asthmasevere asthma
Beyond the preview
Go deeper on IRCT20100102002954N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100102002954N21.